Key result
An automated hybrid bioelectronic system allowed safe, effective, repetitive, and shock-free detection and termination of atrial fibrillation in adult rats.
Why the study?
Restoration of sinus rhythm in AF often requires in-hospital high-voltage shocks, precluding ambulatory termination despite the need for continuous, rapid restoration.
Does an automated hybrid bioelectronic system using optogenetics terminate atrial fibrillation in adult rats?
Does an automated hybrid bioelectronic system using optogenetics terminate atrial fibrillation in adult rats?
Answers are grounded in this paper and cite their sources.
An optogenetic-based automated hybrid bioelectronic system successfully detected and terminated atrial fibrillation in a shock-free manner in adult rats, showing translational potential for ambulatory AF treatment.
Because of suboptimal therapeutic strategies, restoration of sinus rhythm in symptomatic atrial fibrillation (AF) often requires in-hospital delivery of high-voltage shocks, thereby precluding ambulatory AF termination. Continuous, rapid restoration of sinus rhythm is desired given the recurring and progressive nature of AF. Here, we present an automated hybrid bioelectronic system for shock-free termination of AF that enables the heart to act as an electric current generator for autogenous restoration of sinus rhythm. We show that local, right atrial delivery of adenoassociated virus vectors encoding a light-gated depolarizing ion channel results in efficient and spatially confined transgene expression. Activation of an implanted intrathoracic light-emitting diode device allows for termination of AF by illuminating part of the atria. Combining this newly obtained antiarrhythmic effector function of the heart with the arrhythmia detector function of a machine-based cardiac rhythm monitor in the closed chest of adult rats allowed automated and rapid arrhythmia detection and termination in a safe, effective, repetitive, yet shock-free manner. These findings hold translational potential for the development of shock-free antiarrhythmic device therapy for ambulatory treatment of AF.
No takes yet. Share an insight, caveat, or question.
Nyns et al. (2019) studied Atrial fibrillation. Automated hybrid bioelectronic system was evaluated on Arrhythmia detection and termination. An automated hybrid bioelectronic system allowed safe, effective, repetitive, and shock-free detection and termination of atrial fibrillation in adult rats.
Synapse has enriched 10 related papers. Consider them for comparative context: